Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., . . . Keech, A. (2009). Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. American Diabetes Association.

Scott, Russell, Richard O'Brien, Greg Fulcher, Chris Pardy, Michael d'Emden, Dana Tse, Marja-Riitta Taskinen, Christian Ehnholm, và Anthony Keech. Effects of Fenofibrate Treatment On Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. American Diabetes Association, 2009.

Scott, Russell, et al. Effects of Fenofibrate Treatment On Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. American Diabetes Association, 2009.